Clinical trial
Clinical Trials of Phase 1, 2 of Nanocovax Manufactured by Nanogen
NCT04683484 is registered in ClinicalTrials.gov with Nanogen Pharmaceutical Biotechnology Joint Stock Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Trials of Phase 1, 2 of Nanocovax Manufactured by Nanogen
- Lead sponsor
- Nanogen Pharmaceutical Biotechnology Joint Stock Company
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- December 10, 2020
- Completion date
- August 10, 2021
- Enrollment
- 620 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.